CNBC Reports on Intelligent Fingerprinting’s US Distribution Agreement

CNBC

Originally published by CNBC.

Start Up Hopes to Put Drug Test at Companies’ Fingertips

If you invented a drug test that detects illegal substance levels via fingerprints, where might you sell it?

You may seek the country with the highest imprisonment rates in the developed world, and the birthplace of the crime-solving FBI.

Indeed, Intelligent Fingerprinting, a private, U.K.-based company developing said device, raised approximately $5 million in March alone from angel investors in America.

The portable device, informally called the “IFP”, detects drug use from the sweat in fingerprints. The company says heroin, cocaine and cannabis use can be detected in less than 10 minutes.

One Texas-based company, Smart Start, specialises in alcohol monitoring for drivers and is so jazzed about the new product that it has bought a 35 per cent stake in Intelligent Fingerprinting, joined the board of directors, and signed on as a distributor.

The partnership is mutually beneficial. Intelligent Fingerprinting gains access to key law enforcement markets it would not have on its own, and Smart Start, in turn, gets a cut of the profits — so Smart Start’s CEO Lamar Ball is already thinking big.

“So far, we deal with police and highway patrol, who benefit from a roadside product,” he said. “Blood and urine testing is very time consuming. But we want to grow, and expand into the corporate and prison marketplaces.”

Ball claims the U.S. drug testing marketplace is a ”$2 billion business,” of which prisons account for 10 per cent, and corporations about 50 per cent of market share.

He concedes that the largest market will be the toughest to crack.

“It’s harder to work the corporate market than prisons,” he said. “Companies are often already using third-party providers, like wellness programmes, to get the backgrounds of new employees so they already have the relationships.”

Even with that challenge, tech analyst Jeff Kagan thinks the market timing is good.

“If it works, it could be a good thing for companies to uncover a problem earlier rather than later,” said Kagan. “Much of corporate America tries to have as much control as possible, but invasion of privacy will be a factor here as well.”

As Kagan spoke, the Governor of Florida, Rick Scott, was in court over this very issue of drug-testing and privacy, or as the judge put it, “unreasonable search.” Scott’s order to randomly test state employees for drugs was ruled unconstitutional just last week.

Although the case concerns public-sector drug testing, it caught Intelligent Fingerprinting’s attention.

“You can only test within the framework of corporate policy, be it pre-employment drug testing or randomly,” said Dr. Paul Yates, business development manager at Intelligent Fingerprinting. The main hurdle for us is companies’ initial response to negotiating that policy.”

For now, the device is moving forward in its development, and Yates will leave the rulebook up to the lawyers.

The goal, Yates says, is to match the device’s replaceable Cartridge tests to a company’s individual requirements.

The device has been approved with a U.K. patent to test for cannabis, cocaine and heroin; Intelligent Fingerprinting also plans to add testing for amphetamines and PCP.

Meanwhile, more structural capabilities are in the works.

“We think this device can help law enforcement officials use fingerprints to link a person back to a police database, for profiling. We’re looking to add that,” said Yates.

His patience, along with the new capabilities, are being tested. The product is still pending both patent and FDA approval in the U.S., which Yates expects should allow for sales to begin by the end of 2012.

The next challenge: sales. How well they do on that end will depend upon on what they can offer companies in the way of saving money.

Smart Start estimates the device will sell for less than $5,000, depending on additional features that might be requested. A standard five-drug test Cartridge, which aligns with the U.S. National Institute on Drug Abuse’s (NIDA) standard panel, would be less than $10, according to Yates.

That $5,000 may sound steep. But Yates says in most cases it would be cheaper than standard blood and urine tests, given the facility and personnel costs involved.

“There are many ways of beating urine tests, and because of that, there’s a lot of prep work to be done,” Yates says. “Samples have to be witnessed by another individual; it requires time, effort and personnel.”

So far, Yates says their closest competitor is German-based Draeger, which offers oral screening devices that can also test for multiple drugs. The manufacturer’s list price for the Drager DrugTest 5000, is under $4,000.

Ultimately, the final pricing call, Smart Start’s Lamar Ball stresses, “will meet market conditions.”

While Intelligent Fingerprinting still has some hurdles to face before it sees success in the U.S. market, the bottom line, says tech analyst Kagan, is that the new entry moves the industry forward. And that’s a positive.

“Will this change the drug-testing industry?” he asks. “No. But it will add a whole new chapter to the book.”

Meet The Author

Intelligent Fingerprinting

Intelligent Fingerprinting

Related Articles

Skilled construction worker

Does workplace drug testing affect staff retention? It can. An intrusive, heavy-handed approach to drug testing at work can quietly push good employees towards the door. People do not forget an experience that felt invasive or accusatory, and for a skilled worker with options, that is one more reason to look elsewhere. This article looks…

Fingerprint drug testing during procurement

Do contracts require a drug and alcohol policy? Increasingly, the answer is yes. For a few sectors it is a legal requirement; for many more it has become a commercial one, written into the pre-qualification questionnaires and supply-chain standards that decide who gets shortlisted. Either way, the direction of travel is the same: a documented…

Fingerprint drug testing cartridge

Is workplace drug testing worth it? A fair question. Most organisations weigh the cost of testing against zero: the price of the kits versus doing nothing at all. Counted that way, testing will always look like an expense to contain. But that sum measures only one side of the ledger. It ignores what a well-run…

Book A Demo

See the difference fingerprint drug testing can make in your workplace. Request a personalised demonstration today.